Enanta Pharmaceuticals Stock Forecast

Hold candidate since Jun 05, 2026

The Enanta Pharmaceuticals stock price fell by -3.84% on the last day (Friday, 5th Jun 2026) from $11.73 to $11.28. During the last trading day the stock fluctuated 3.82% from a day low at $11.25 to a day high of $11.68. The price has fallen in 7 of the last 10 days and is down by -18.44% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -182 thousand shares and in total, 0 shares were bought and sold for approximately $0 .

The stock is at the lower part of a very wide and horizontal trend in the short term, and normally this may pose a good buying opportunity, though a breakdown through the bottom trend line at $11.25 will give a strong sell signal and a trend shift may be expected. Given the current horizontal trend, you can expect Enanta Pharmaceuticals stock with a 90% probability to be traded between $11.38 and $15.70 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.

ENTA Signals & Forecast

There are few to no technical positive signals at the moment. The Enanta Pharmaceuticals stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $12.19 and $13.63. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, June 04, 2026, and so far it has fallen -3.84%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Enanta Pharmaceuticals stock

Enanta Pharmaceuticals finds support from accumulated volume at $11.24 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved $0.430 between high and low, or 3.82%. For the last week the stock has had daily average volatility of 6.18%

Our recommended stop-loss: $10.61 (-5.92%) (This stock has very low daily movements and this gives very low risk. There is a sell signal from a pivot top found 1 day ago.)

Trading Expectations (ENTA) For The Upcoming Trading Day Of Monday 8th

For the upcoming trading day on Monday, 8th we expect Enanta Pharmaceuticals to open at $11.40, and during the day (based on 14 day Average True Range), to move between $10.92 and $11.64, which gives a possible trading interval of +/-$0.717 (+/-6.57%) up or down from last closing price. If Enanta Pharmaceuticals takes out the full calculated possible swing range there will be an estimated 6.57% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $11.24 (0.35%) than the resistance at $12.51 (10.90%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Enanta Pharmaceuticals stock A Buy?

Enanta Pharmaceuticals holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold candidate.

Current score: -0.781 Hold/Accumulate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on June 8, 2026 - $11.40 ( 1.09%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk